These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27476886)

  • 1. Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience.
    Zhu H; Fox EE; Baraniuk S; Holcomb JB; Wade CE; Del Junco DJ; Tilley BC;
    Injury; 2016 Oct; 47(10):2131-2137. PubMed ID: 27476886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pragmatic randomized optimal platelet and plasma ratios trial: what does it mean for remote damage control resuscitation?
    Yonge JD; Schreiber MA
    Transfusion; 2016 Apr; 56 Suppl 2():S149-56. PubMed ID: 27100751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
    Holcomb JB; Tilley BC; Baraniuk S; Fox EE; Wade CE; Podbielski JM; del Junco DJ; Brasel KJ; Bulger EM; Callcut RA; Cohen MJ; Cotton BA; Fabian TC; Inaba K; Kerby JD; Muskat P; O'Keeffe T; Rizoli S; Robinson BR; Scalea TM; Schreiber MA; Stein DM; Weinberg JA; Callum JL; Hess JR; Matijevic N; Miller CN; Pittet JF; Hoyt DB; Pearson GD; Leroux B; van Belle G;
    JAMA; 2015 Feb; 313(5):471-82. PubMed ID: 25647203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic impact of transfusion ratios on outcomes in severely injured patients: Targeted machine learning analysis of the Pragmatic, Randomized Optimal Platelet and Plasma Ratios randomized clinical trial.
    Nguyen M; Pirracchio R; Kornblith LZ; Callcut R; Fox EE; Wade CE; Schreiber M; Holcomb JB; Coyle J; Cohen M; Hubbard A
    J Trauma Acute Care Surg; 2020 Sep; 89(3):505-513. PubMed ID: 32520897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness evaluation of the PROPPR trial transfusion protocols.
    Callcut RA; Simpson KN; Baraniuk S; Fox EE; Tilley BC; Holcomb JB;
    Transfusion; 2020 May; 60(5):922-931. PubMed ID: 32358836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation.
    Baraniuk S; Tilley BC; del Junco DJ; Fox EE; van Belle G; Wade CE; Podbielski JM; Beeler AM; Hess JR; Bulger EM; Schreiber MA; Inaba K; Fabian TC; Kerby JD; Cohen MJ; Miller CN; Rizoli S; Scalea TM; O'Keeffe T; Brasel KJ; Cotton BA; Muskat P; Holcomb JB;
    Injury; 2014 Sep; 45(9):1287-95. PubMed ID: 24996573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial.
    Novak DJ; Bai Y; Cooke RK; Marques MB; Fontaine MJ; Gottschall JL; Carey PM; Scanlan RM; Fiebig EW; Shulman IA; Nelson JM; Flax S; Duncan V; Daniel-Johnson JA; Callum JL; Holcomb JB; Fox EE; Baraniuk S; Tilley BC; Schreiber MA; Inaba K; Rizoli S; Podbielski JM; Cotton BA; Hess JR;
    Transfusion; 2015 Jun; 55(6):1331-9. PubMed ID: 25823522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Bayesian Statistics to Reanalyze Data From the Pragmatic Randomized Optimal Platelet and Plasma Ratios Trial.
    Lammers D; Richman J; Holcomb JB; Jansen JO
    JAMA Netw Open; 2023 Feb; 6(2):e230421. PubMed ID: 36811858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive transfusion protocol in adult trauma population.
    Meneses E; Boneva D; McKenney M; Elkbuli A
    Am J Emerg Med; 2020 Dec; 38(12):2661-2666. PubMed ID: 33071074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive transfusion: red blood cell to plasma and platelet unit ratios for resuscitation of massive hemorrhage.
    Murphy CH; Hess JR
    Curr Opin Hematol; 2015 Nov; 22(6):533-9. PubMed ID: 26390160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Evaluation of a Blood Transfusion Protocol for Patients Undergoing Cardiac Operations.
    Squiers JJ; Baumgarten H; Filardo G; Sass D; Pollock B; Edgerton J; Marcel R; DiMaio JM; Smith RL
    Ann Thorac Surg; 2020 Jul; 110(1):144-151. PubMed ID: 31770507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial.
    Cardenas JC; Zhang X; Fox EE; Cotton BA; Hess JR; Schreiber MA; Wade CE; Holcomb JB;
    Blood Adv; 2018 Jul; 2(14):1696-1704. PubMed ID: 30030268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital variation in adoption of balanced transfusion practices among injured patients requiring blood transfusions.
    Nasca B; Reddy S; Furmanchuk A; Lundberg A; Kong N; Andrei AC; Theros J; Thomas A; Ingram M; Sanchez J; Slocum J; Stey AM
    Surgery; 2024 Oct; 176(4):1273-1280. PubMed ID: 39069394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive transfusion: blood component ratios.
    Lal DS; Shaz BH
    Curr Opin Hematol; 2013 Nov; 20(6):521-5. PubMed ID: 24104413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-based differences in transfusion need after severe injury: Findings of the PROPPR study.
    McCrum ML; Leroux B; Fang T; Bulger E; Arbabi S; Wade CE; Fox E; Holcomb JB; Robinson B;
    Surgery; 2019 Jun; 165(6):1122-1127. PubMed ID: 30871812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective.
    Holcomb JB; Pati S
    Hematology Am Soc Hematol Educ Program; 2013; 2013():656-9. PubMed ID: 24319247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation.
    Rosenberg EM; Chambers LA; Gunter JM; Good JA
    Pediatrics; 1994 Sep; 94(3):341-6. PubMed ID: 8065860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review.
    McQuilten ZK; Crighton G; Brunskill S; Morison JK; Richter TH; Waters N; Murphy MF; Wood EM
    Transfus Med Rev; 2018 Jan; 32(1):6-15. PubMed ID: 28803752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.